While finding a biomarker for Parkinson’s disease that would let physicians screen for or track progression of the disease remains an elusive goal, neuroscientists have shown that a noninvasive brain scanning technique offers promise.
While finding a biomarker for Parkinson’s disease that would let physicians screen for or track progression of the disease remains an elusive goal, neuroscientists have shown that a noninvasive brain scanning technique offers promise.